Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Castleman's disease.

Louis M Germaine1, Jeffrey H Newhouse

  • 1College of Physicians and Surgeons, New York-Presbyterian Hospital, Milstein Hospital Building, Room 3-250, 177 Fort Washington Avenue, New York, NY 10032-3784, USA.

Clinical Imaging
|October 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mean creatinine decrease after administration of intravenous contrast in patients with renal dysfunction: implications for assessment of post-contrast nephrotoxicity.

Acta radiologica (Stockholm, Sweden : 1987)·2025
Same author

Share of Diagnostic Imaging Interpretation: Radiology and Other Specialties.

Journal of the American College of Radiology : JACR·2024
Same author

A Control Group Is Necessary for Experiments Designed to Quantitate Nephrotoxic Risk Attributed to Contrast Media.

AJR. American journal of roentgenology·2023
Same author

Diagnostic Accuracy of Unenhanced Computed Tomography for Evaluation of Acute Abdominal Pain in the Emergency Department.

JAMA surgery·2023
Same author

ACR Statement on Use of Iodinated Contrast Material for Medical Imaging in Young Children and Need for Thyroid Monitoring.

Journal of the American College of Radiology : JACR·2022
Same author

Statement from the ACR Committee on Drugs and Contrast Media on the Intravenous Iodinated Contrast Media Shortage.

Journal of the American College of Radiology : JACR·2022
Same journal

Visibility patterns of architectural distortion on synthesized 2D vs. digital breast tomosynthesis and their diagnostic implications.

Clinical imaging·2026
Same journal

Diagnostic performance of CT-based node-RADS for detecting metastatic lymph nodes in melanoma and comparison with short-axis and roundness index.

Clinical imaging·2026
Same journal

Identifying hepatocellular carcinoma patients at risk of early non-response after first-cycle transarterial chemoembolization: A reproducible machine learning study.

Clinical imaging·2026
Same journal

Comment on "The importance of FDG avidity in incidental thyroid nodules on FDG PET/CT".

Clinical imaging·2026
Same journal

Lipiodol in embolization therapy: Evolution from a diagnostic to a therapeutic agent.

Clinical imaging·2026
Same journal

Musculoskeletal abnormalities: A clue to systemic diseases.

Clinical imaging·2026
See all related articles

This study details a rare retroperitoneal Castleman's disease case with unique MR imaging features. It also reviews imaging findings for Castleman's disease to aid diagnosis.

Area of Science:

  • Radiology
  • Oncology
  • Pathology

Background:

  • Castleman's disease is a rare lymphoproliferative disorder.
  • Hyaline vascular Castleman's disease is the most common subtype.
  • Retroperitoneal involvement is uncommon.

Observation:

  • A case of retroperitoneal hyaline vascular Castleman's disease is presented.
  • Unusual magnetic resonance (MR) imaging findings were observed.
  • These findings differ from previously reported imaging characteristics.

Findings:

  • Detailed description of the unique MR imaging features of retroperitoneal Castleman's disease.
  • Comparison with existing literature on imaging findings in Castleman's disease.
  • Highlighting the diagnostic challenges posed by atypical presentations.

Related Experiment Videos

Implications:

  • Enhanced understanding of the diverse MR imaging spectrum of Castleman's disease.
  • Improved diagnostic accuracy for retroperitoneal Castleman's disease.
  • Guidance for radiologists and clinicians in identifying this rare condition.